Assembly Biosciences (ASMB) EBT Margin Growth (1y) (2018 - 2026)
Assembly Biosciences (ASMB) EBT Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -153.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -571.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 452.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1,076.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -9,422.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -392.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1,911.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 29,565.00 |
| 10 | Assembly Biosciences | 670.88 Mn | 350.52 Mn | - | 7,710.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7,710.00 |
| Mar 31, 2026 | -3,643.00 |
| Dec 31, 2025 | 19,353.00 |
| Sep 30, 2025 | 5,520.00 |
| Jun 30, 2025 | 1,999.00 |
| Mar 31, 2025 | 5,092.00 |
| Dec 31, 2024 | 1,106.00 |
| Sep 30, 2021 | -42,147.00 |
| Dec 31, 2020 | -321,746.00 |
| Sep 30, 2020 | 58,144.00 |
| Jun 30, 2020 | 61,957.00 |
| Mar 31, 2020 | 4,335.00 |
| Dec 31, 2019 | 8,623.00 |
| Sep 30, 2019 | -8,852.00 |
| Jun 30, 2019 | 23,295.00 |
| Mar 31, 2019 | -24,071.00 |
| Dec 31, 2018 | -30,939.00 |
| Sep 30, 2018 | -3,989.00 |
| Jun 30, 2018 | -25,464.00 |
| Mar 31, 2018 | 1.36 Mn |